Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Reuter, U.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(9)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(7)
+
-
Creation Date
2021
(4)
+
-
2010
(2)
+
-
2019
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(10)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(10)
+
-
Topic
Migraine
(2)
+
-
Prevention
(2)
+
-
Author
Reuter, U.
(10)
+
-
Ferrari, M.D.
(6)
+
-
Lanteri-Minet, M.
(5)
+
-
Ashina, M.
(4)
+
-
Goadsby, P.J.
(4)
+
-
Martelletti, P.
(4)
+
-
Mitsikostas, D.D.
(4)
+
-
Sacco, S.
(4)
+
-
Wen, S.H.
(4)
+
-
Bendtsen, L.
(3)
+
-
Diener, H.C.
(3)
+
-
Hours-Zesiger, P.
(3)
+
-
Klatt, J.
(3)
+
-
Terwindt, G.
(3)
+
-
Davis, C.
(2)
+
-
European COL-144 Investigators
(2)
+
-
Farkkila, M.
(2)
+
-
Katsarava, Z.
(2)
+
-
Krauss, M.
(2)
+
-
Lampl, C.
(2)
+
-
Lima, G.P.D.
(2)
+
-
Pilgrim, A.
(2)
+
-
Sinclair, A.J.
(2)
+
-
Tenenbaum, N.
(2)
+
-
Show more
Language
en
(10)
+
-
Search results
(1 - 10 of 10)
show grid
show list
save search
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention-2022 update
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study
Diagnosis and management of migraine in ten steps
Long-term efficacy and safety of erenumab results from 64 weeks of the LIBERTY study
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention (vol 20, 6, 2019)
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial